Logo image of RZLV

REZOLVE AI PLC (RZLV) Stock Fundamental Analysis

NASDAQ:RZLV - GB00BQH8G337 - Common Stock

5.62 USD
+1.08 (+23.69%)
Last: 9/9/2025, 8:08:15 PM
5.8 USD
+0.18 (+3.2%)
Pre-Market: 9/10/2025, 5:33:24 AM
Fundamental Rating

1

Overall RZLV gets a fundamental rating of 1 out of 10. We evaluated RZLV against 280 industry peers in the Software industry. RZLV may be in some trouble as it scores bad on both profitability and health. RZLV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RZLV had negative earnings in the past year.
In the past year RZLV has reported a negative cash flow from operations.
In the past 5 years RZLV always reported negative net income.
RZLV had a negative operating cash flow in each of the past 5 years.
RZLV Yearly Net Income VS EBIT VS OCF VS FCFRZLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

RZLV's Return On Assets of -872.47% is on the low side compared to the rest of the industry. RZLV is outperformed by 98.57% of its industry peers.
Industry RankSector Rank
ROA -872.47%
ROE N/A
ROIC N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RZLV Yearly ROA, ROE, ROICRZLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

With an excellent Gross Margin value of 81.84%, RZLV belongs to the best of the industry, outperforming 88.21% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for RZLV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RZLV Yearly Profit, Operating, Gross MarginsRZLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

More info and screens

0

2. Health

2.1 Basic Checks

RZLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RZLV has more shares outstanding
Compared to 1 year ago, RZLV has a worse debt to assets ratio.
RZLV Yearly Shares OutstandingRZLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M
RZLV Yearly Total Debt VS Total AssetsRZLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

RZLV has an Altman-Z score of -26.76. This is a bad value and indicates that RZLV is not financially healthy and even has some risk of bankruptcy.
RZLV has a worse Altman-Z score (-26.76) than 94.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -26.76
ROIC/WACCN/A
WACC9.4%
RZLV Yearly LT Debt VS Equity VS FCFRZLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

RZLV has a Current Ratio of 0.23. This is a bad value and indicates that RZLV is not financially healthy enough and could expect problems in meeting its short term obligations.
RZLV has a Current ratio of 0.23. This is amonst the worse of the industry: RZLV underperforms 96.07% of its industry peers.
A Quick Ratio of 0.23 indicates that RZLV may have some problems paying its short term obligations.
RZLV's Quick ratio of 0.23 is on the low side compared to the rest of the industry. RZLV is outperformed by 96.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
RZLV Yearly Current Assets VS Current LiabilitesRZLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for RZLV have decreased strongly by -2570.28% in the last year.
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.43%

3.2 Future

RZLV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -38.87% yearly.
Based on estimates for the next years, RZLV will show a very strong growth in Revenue. The Revenue will grow by 1864.27% on average per year.
EPS Next Y-183.33%
EPS Next 2Y-38.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14112.7%
Revenue Next 2Y1864.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

RZLV Yearly Revenue VS EstimatesRZLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 20M 40M 60M 80M 100M
RZLV Yearly EPS VS EstimatesRZLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RZLV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RZLV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RZLV Price Earnings VS Forward Price EarningsRZLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RZLV Per share dataRZLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

RZLV's earnings are expected to decrease with -38.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-38.87%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RZLV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REZOLVE AI PLC

NASDAQ:RZLV (9/9/2025, 8:08:15 PM)

Premarket: 5.8 +0.18 (+3.2%)

5.62

+1.08 (+23.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst Owners2.56%
Inst Owner ChangeN/A
Ins Owners34.71%
Ins Owner ChangeN/A
Market Cap1.48B
Analysts81.67
Price Target6.25 (11.21%)
Short Float %7.72%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.41%
PT rev (3m)8.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7890.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -872.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.84%
FCFM N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1566.18%
Cap/Sales 1878.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z -26.76
F-Score5
WACC9.4%
ROIC/WACCN/A
Cap/Depr(3y)772.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-493.89%
EPS Next Y-183.33%
EPS Next 2Y-38.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%29.43%
Revenue Next Year14112.7%
Revenue Next 2Y1864.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4849.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.09%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1253.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1063.59%
OCF growth 3YN/A
OCF growth 5YN/A